ABBV-701

DRUG2 trials

Sponsors

AbbVie

Conditions

Crohn's DiseaseHealthy VolunteerUlcerative Colitis

Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcutaneous or Intravenous Doses of ABBV-701 in Healthy Adult Western and Asian Participants

Active, not recruitingNCT06895343

AbbVieHealthy Volunteer

Start: 2025-04-03End: 2026-11-01Updated: 2026-03-02

Phase 2

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Not yet recruitingNCT07697456

AbbVieCrohn's Disease, Ulcerative Colitis

Start: 2026-07-24End: 2031-10-01Target: 2000Updated: 2026-07-13